Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Lifestyle comes first
Apply the product on your face and neck
Another study developed phasetransitional Pt (IV) NPcRGD nanoparticles with a hybrid lipidpolymer shell for ovarian cancer, which are both GSHsensitive and ultrasoundresponsive, demonstrating enhanced therapeutic efficacy and reduced side effects in in vivo models [121]
PMID 22995213
By focusing on these strategies and turning innovations into actual therapies, we can fully realize the potential of nanomedicines and make them more widely available to help more patients
US$ 20.34
US$ 25.95
US$ 27.67
US$ 21.02
